Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Anemia

  Free Subscription


Articles published in Br J Haematol

Retrieve available abstracts of 187 articles:
HTML format



Single Articles


    November 2021
  1. HALL R, Meenan J, Mihalca D, Katumba A, et al
    The real impact of COVID-19 on an East London Sickle cell population: results of a service-wide survey.
    Br J Haematol. 2021;195:532-535.
    PubMed    


    September 2021
  2. MASLAH N, Ravdan O, Drevon L, Verger E, et al
    Revisiting Diagnostic performances of serum erythropoietin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement.
    Br J Haematol. 2021 Sep 25. doi: 10.1111/bjh.17848.
    PubMed     Abstract available


  3. BARCELLINI W, Fattizzo B, Giannotta JA, Quattrocchi L, et al
    COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey.
    Br J Haematol. 2021;194:854-856.
    PubMed    


  4. MUNARETTO V, Voi V, Palazzi G, Notarangelo LD, et al
    Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned.
    Br J Haematol. 2021;194:851-854.
    PubMed    


    July 2021
  5. FATTIZZO B, Rizzo L, Giannotta JA, Mazzon F, et al
    Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes: a second honeymoon?
    Br J Haematol. 2021 Jul 26. doi: 10.1111/bjh.17722.
    PubMed    


    June 2021
  6. PATON C, Mathews L, Groarke EM, Rios O, et al
    COVID-19 infection in patients with severe aplastic anaemia.
    Br J Haematol. 2021;193:902-905.
    PubMed    


  7. HANDS K, Taylor C, Kotze A, Richards T, et al
    Preoperative patient blood management during the SARS-CoV-2 pandemic.
    Br J Haematol. 2021;193:1087-1092.
    PubMed    


  8. STEINBERG MH
    HbA2 induction: the merit of pancellularity in sickle cell disease.
    Br J Haematol. 2021;193:1032-1033.
    PubMed    


  9. HILLS RK
    Diagnosing Diamond-Blackfan anaemia: 'Vorsprung durch Technik'.
    Br J Haematol. 2021;193:1030-1031.
    PubMed    


  10. BLAISE D, Savani BN
    Alternative donor transplantation for severe aplastic anaemia in 2021: haplo donor, cord blood or both?
    Br J Haematol. 2021;193:863-864.
    PubMed    


  11. PORCU S, Simbula M, Marongiu MF, Perra A, et al
    Delta-globin gene expression improves sickle cell disease in a humanised mouse model.
    Br J Haematol. 2021;193:1228-1237.
    PubMed     Abstract available


  12. VAN DOOIJEWEERT B, Broeks MH, van Beers EJ, Verhoeven-Duif NM, et al
    Dried blood spot metabolomics reveals a metabolic fingerprint with diagnostic potential for Diamond Blackfan Anaemia.
    Br J Haematol. 2021;193:1185-1193.
    PubMed     Abstract available


  13. LIANG Y, Zhang X, Liu Y, Wang L, et al
    GATA zinc finger domain-containing protein 2A (GATAD2A) deficiency reactivates fetal haemoglobin in patients with beta-thalassaemia through impaired formation of methyl-binding domain protein 2 (MBD2)-containing nucleosome remodelling and deacetylatio
    Br J Haematol. 2021;193:1220-1227.
    PubMed     Abstract available


  14. CHILDS RW, Tian X, Vo P, Purev E, et al
    Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome.
    Br J Haematol. 2021;193:951-960.
    PubMed     Abstract available


  15. MAITLAND K, Kiguli S, Olupot-Olupot P, Opoka RO, et al
    Transfusion management of severe anaemia in African children: a consensus algorithm.
    Br J Haematol. 2021;193:1247-1259.
    PubMed     Abstract available


  16. LAAS C, Lambert C, Senior McKenzie T, Sheldon E, et al
    Improving the laboratory diagnosis of pyruvate kinase deficiency.
    Br J Haematol. 2021;193:994-1000.
    PubMed     Abstract available


  17. JANG T, Mo G, Stewart C, Egini O, et al
    Antibiotic use in adults during sickle cell vaso-occlusive crisis: Is it time for a controlled trial?
    Br J Haematol. 2021;193:1281-1283.
    PubMed    


  18. MARTINO S, Arlet JB, Odievre MH, Jullien V, et al
    Deficient mitophagy pathways in sickle cell disease.
    Br J Haematol. 2021;193:988-993.
    PubMed     Abstract available


  19. XU Y, Alfaro-Magallanes VM, Babitt JL
    Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders.
    Br J Haematol. 2021;193:882-893.
    PubMed     Abstract available


  20. JUNG M, Mehta PA, Jiang CS, Rosti RO, et al
    Comparison of the clinical phenotype and haematological course of siblings with Fanconi anaemia.
    Br J Haematol. 2021;193:971-975.
    PubMed     Abstract available


    May 2021
  21. UYOGA S, George EC, Bates I, Olupot-Olupot P, et al
    Point-of-care haemoglobin testing in African hospitals: a neglected essential diagnostic test.
    Br J Haematol. 2021 May 15. doi: 10.1111/bjh.17431.
    PubMed     Abstract available


  22. BARCELLINI W, Colombatti R
    The impact of Parvovirus B19 on hereditary haemolytic anaemias.
    Br J Haematol. 2021;193:703-704.
    PubMed    


  23. BOOTH GS, Savani BN, Langston AA
    Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematopoietic cell transplantation.
    Br J Haematol. 2021;193:701-702.
    PubMed    


  24. ELBADRY MI, Khaled SAA, Ahmed NM, Abudeif A, et al
    Acute human parvovirus B19 infection triggers immune-mediated transient bone marrow failure syndrome, extreme direct hyperbilirubinaemia and acute hepatitis in patients with hereditary haemolytic anaemias: multicentre prospective pathophysiological st
    Br J Haematol. 2021;193:827-840.
    PubMed     Abstract available


  25. LONGVAL T, Galimard JE, Lepretre AC, Suarez F, et al
    Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study.
    Br J Haematol. 2021;193:814-826.
    PubMed     Abstract available


  26. VINCHI F, Sparla R, Passos ST, Sharma R, et al
    Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.
    Br J Haematol. 2021;193:637-658.
    PubMed     Abstract available


  27. RUND D
    Intravenous iron: do we adequately understand the short- and long-term risks in clinical practice?
    Br J Haematol. 2021;193:466-480.
    PubMed     Abstract available


  28. SARAF SL, Zhang X, Shah BN, Raslan R, et al
    Engulfment and cell motility 1 (ELMO1) and apolipoprotein A1 (APOA1) as candidate genes for sickle cell nephropathy.
    Br J Haematol. 2021;193:628-632.
    PubMed     Abstract available


  29. DENTON CC, Detterich JA, Coates TD, Wood JC, et al
    Kidney iron deposition by R2* is associated with haemolysis and urinary iron.
    Br J Haematol. 2021;193:633-636.
    PubMed     Abstract available


    April 2021
  30. BERNARD F, Uppungunduri CRS, Meyer S, Cummins M, et al
    Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience.
    Br J Haematol. 2021 Apr 14. doi: 10.1111/bjh.17418.
    PubMed     Abstract available


  31. CALABRETTA E, Moraleda JM, Iacobelli M, Jara R, et al
    COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.
    Br J Haematol. 2021;193:43-51.
    PubMed    


  32. BENNETT R, Ruskova A
    Atezolizumab-induced pure red cell aplasia.
    Br J Haematol. 2021;193:10.
    PubMed    


  33. LADU AI, Aiyenigba AO, Adekile A, Bates I, et al
    The spectrum of splenic complications in patients with sickle cell disease in Africa: a systematic review.
    Br J Haematol. 2021;193:26-42.
    PubMed     Abstract available


  34. SHAFIEE S, Gelebart P, Popa M, Hellesoy M, et al
    Preclinical characterisation and development of a novel myelodysplastic syndrome-derived cell line.
    Br J Haematol. 2021;193:415-419.
    PubMed    


  35. CHENG Y, Shang X, Chen D, Pang D, et al
    MicroRNA-2355-5p regulates gamma-globin expression in human erythroid cells by inhibiting KLF6.
    Br J Haematol. 2021;193:401-405.
    PubMed     Abstract available


  36. QUINTINO DE OLIVEIRA B, Catto LFB, Santana BAA, Tellechea MF, et al
    Eltrombopag preferentially expands haematopoietic multipotent progenitors in human aplastic anaemia.
    Br J Haematol. 2021;193:410-414.
    PubMed     Abstract available


    March 2021
  37. SAULSBERRY-ABATE AC, Partanen M, Porter JS, Podila PSB, et al
    Cognitive performance as a predictor of healthcare transition in sickle cell disease.
    Br J Haematol. 2021;192:1082-1091.
    PubMed     Abstract available


  38. AL-SAMKARI H, Addonizio K, Glader B, Morton DH, et al
    The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.
    Br J Haematol. 2021;192:1092-1096.
    PubMed     Abstract available


  39. EGOT M, Lasne D, Poirault-Chassac S, Mirault T, et al
    Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
    Br J Haematol. 2021;192:909-921.
    PubMed     Abstract available


  40. ATAGA KI, Staffa SJ, Brugnara C, Stocker JW, et al
    Haemoglobin response to senicapoc in patients with sickle cell disease: a re-analysis of the Phase III trial.
    Br J Haematol. 2021;192:e129-e132.
    PubMed    


  41. OIKONOMOPOULOU C, Paisiou A, Komitopoulou A, Ioannidou ED, et al
    Increased incidence of autoimmune cytopenias after allogeneic haematopoietic stem cell transplantation using a matched unrelated donor in children with beta-thalassaemia.
    Br J Haematol. 2021;192:e127-e129.
    PubMed    


  42. SACHDEV V, Tian X, Gu Y, Nichols J, et al
    A phenotypic risk score for predicting mortality in sickle cell disease.
    Br J Haematol. 2021;192:932-941.
    PubMed     Abstract available


  43. RIBEIRO PR, Teixeira RDS, Souza AR, Pereira TCS, et al
    Blood plasma metabolomics of children and adolescents with sickle cell anaemia treated with hydroxycarbamide: a new tool for uncovering biochemical alterations.
    Br J Haematol. 2021;192:922-931.
    PubMed     Abstract available


    February 2021
  44. CAIRO MS, Savani BN
    Haematopoietic progenitor cell transplantation in adults with symptomatic sickle cell disease: the time has arrived.
    Br J Haematol. 2021;192:678-680.
    PubMed    


  45. OLSON TS
    Paediatric severe aplastic anaemia treatment: where to start?
    Br J Haematol. 2021;192:417-419.
    PubMed    


  46. ALZAHRANI M, Damlaj M, Jeffries N, Alahmari B, et al
    Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.
    Br J Haematol. 2021;192:761-768.
    PubMed     Abstract available


  47. YUAN S, Jordan LC, Davis LT, Cogswell PM, et al
    A cross-sectional, case-control study of intracranial arterial wall thickness and complete blood count measures in sickle cell disease.
    Br J Haematol. 2021;192:769-777.
    PubMed     Abstract available


  48. GROARKE EM, Patel BA, Gutierrez-Rodrigues F, Rios O, et al
    Eltrombopag added to immunosuppression for children with treatment-naive severe aplastic anaemia.
    Br J Haematol. 2021;192:605-614.
    PubMed     Abstract available


  49. HOTINSKI AK, Best OG, Thurgood LA, Lower KM, et al
    A biclonal case of chronic lymphocytic leukaemia with discordant mutational status of the immunoglobulin heavy chain variable region and bimodal CD49d expression.
    Br J Haematol. 2021;192:e77-e81.
    PubMed    


  50. DEMBELE AK, Lapoumeroulie C, Diaw M, Tessougue O, et al
    Cell-derived microparticles and sickle cell disease chronic vasculopathy in sub-Saharan Africa: A multinational study.
    Br J Haematol. 2021;192:634-642.
    PubMed     Abstract available


  51. VITRANO A, Meloni A, Addario Pollina W, Karimi M, et al
    A complication risk score to evaluate clinical severity of thalassaemia syndromes.
    Br J Haematol. 2021;192:626-633.
    PubMed     Abstract available


  52. CASTLEMAN JS, Moise KJ Jr, Kilby MD
    Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation.
    Br J Haematol. 2021;192:425-432.
    PubMed     Abstract available


    January 2021
  53. KULASEKARARAJ AG, Marsh JCW
    Romiplostim in aplastic anaemia - another tool in the armamentarium.
    Br J Haematol. 2021;192:15-16.
    PubMed    


  54. MINGOIA M, Caria CA, Ye L, Asunis I, et al
    Induction of therapeutic levels of HbF in genome-edited primary beta(0) 39-thalassaemia haematopoietic stem and progenitor cells.
    Br J Haematol. 2021;192:395-404.
    PubMed     Abstract available



  55. Developing the evidence base for the management of autoimmune haemolytic anaemia (AIHA): the UK experience.
    Br J Haematol. 2021;192:e54-e57.
    PubMed    


  56. SHARMA POUDYAL B, Gyawali B, Rondelli D
    The need for locally generated data in haematology: a real-world experience of aplastic anaemia in Nepal.
    Br J Haematol. 2021;192:e63-e65.
    PubMed    


  57. GREGOIRE-PELCHAT P, Pastore Y, Robitaille N, LeMay S, et al
    Comparison of two vitamin D supplementation strategies in children with sickle cell disease: a randomized controlled trial.
    Br J Haematol. 2021;192:385-394.
    PubMed     Abstract available


  58. PATEL A, Gan K, Li AA, Weiss J, et al
    Machine-learning algorithms for predicting hospital re-admissions in sickle cell disease.
    Br J Haematol. 2021;192:158-170.
    PubMed     Abstract available


  59. JANG JH, Tomiyama Y, Miyazaki K, Nagafuji K, et al
    Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
    Br J Haematol. 2021;192:190-199.
    PubMed     Abstract available


  60. CHAN LKL, Mak VWM, Chan SCH, Yu ELM, et al
    Liver complications of haemoglobin H disease in adults.
    Br J Haematol. 2021;192:171-178.
    PubMed     Abstract available


  61. MTENGA J, Orf K, Zheng J, Chamba C, et al
    Haematopoietic stem cell transplantation in Tanzania.
    Br J Haematol. 2021;192:17-21.
    PubMed    


  62. SPEICH C, Wegmuller R, Brittenham GM, Zeder C, et al
    Measurement of long-term iron absorption and loss during iron supplementation using a stable isotope of iron ((57) Fe).
    Br J Haematol. 2021;192:179-189.
    PubMed     Abstract available


  63. MANARA R, Dalla Torre A, Lucchetta M, Ermani M, et al
    Visual cortex changes in children with sickle cell disease and normal visual acuity: a multimodal magnetic resonance imaging study.
    Br J Haematol. 2021;192:151-157.
    PubMed     Abstract available


    December 2020
  64. RUND D
    The evolution of clinical research in thalassaemia: where has all the funding gone?
    Br J Haematol. 2020;191:666-667.
    PubMed    


  65. JOBANPUTRA M, Paramore C, Laird SG, McGahan M, et al
    Co-morbidities and mortality associated with transfusion-dependent beta-thalassaemia in patients in England: a 10-year retrospective cohort analysis.
    Br J Haematol. 2020;191:897-905.
    PubMed     Abstract available


  66. URIO F, Nkya S, Rooks H, Mgaya JA, et al
    F cell numbers are associated with an X-linked genetic polymorphism and correlate with haematological parameters in patients with sickle cell disease.
    Br J Haematol. 2020;191:888-896.
    PubMed     Abstract available


  67. FORTE S, Eng B, Verhovsek M, Soulieres D, et al
    Microcytosis in patients with haemoglobin C trait: is alpha-thalassaemia trait to blame?
    Br J Haematol. 2020;191:e129-e131.
    PubMed    


  68. TANG D, Liu S, Sun H, Qin X, et al
    All-trans-retinoic acid shifts Th1 towards Th2 cell differentiation by targeting NFAT1 signalling to ameliorate immune-mediated aplastic anaemia.
    Br J Haematol. 2020;191:906-919.
    PubMed     Abstract available


  69. PECKER LH, Hussain S, Christianson MS, Lanzkron S, et al
    Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide.
    Br J Haematol. 2020;191:880-887.
    PubMed     Abstract available


  70. VALI S, Mukhtar S, Nandi A, Wilson K, et al
    Cumulative outcome of pre-implantation genetic diagnosis for sickle cell disease: a 5-year review.
    Br J Haematol. 2020;191:875-879.
    PubMed     Abstract available


    November 2020
  71. VERLHAC S, Gabor F, Paillard C, Chateil JF, et al
    Improved stenosis outcome in stroke-free sickle cell anemia children after transplantation compared to chronic transfusion.
    Br J Haematol. 2020 Nov 20. doi: 10.1111/bjh.17178.
    PubMed     Abstract available


  72. WEI Z, Yang G, Huang Y, Peng P, et al
    A 15-years follow-up of deferasirox in beta-thalassaemia major patients with iron overload.
    Br J Haematol. 2020;191:e81-e83.
    PubMed    


  73. PEZINA-CANTU C, Gomez-De Leon A, Jaime-Perez JC, Colunga-Pedraza P, et al
    Pernicious anaemia can be treated effectively with a single high dose of cobalamin.
    Br J Haematol. 2020;191:e97-e100.
    PubMed    


  74. SIRIWORADETKUN S, Thubthed R, Thiengtavor C, Paiboonsukwong K, et al
    Elevated levels of circulating monocytic myeloid derived suppressor cells in splenectomised beta-thalassaemia/HbE patients.
    Br J Haematol. 2020;191:e72-e76.
    PubMed    


  75. HAN J, Holden CC, Ahluwalia AY, Molokie RE, et al
    Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease.
    Br J Haematol. 2020;191:e70-e72.
    PubMed    


  76. PEFFAULT DE LATOUR R, Brodsky RA, Ortiz S, Risitano AM, et al
    Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.
    Br J Haematol. 2020;191:476-485.
    PubMed     Abstract available


  77. TOLE S, Dhir P, Pugi J, Drury LJ, et al
    Genotype-phenotype correlation in children with hereditary spherocytosis.
    Br J Haematol. 2020;191:486-496.
    PubMed     Abstract available


    October 2020
  78. HERISHANU Y, Levi S, Kamdjou T, Bornstein Y, et al
    Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Br J Haematol. 2020 Oct 23. doi: 10.1111/bjh.17105.
    PubMed    


  79. SHEHA D, El-Shayeb M, Eid Y, Amin M, et al
    Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection.
    Br J Haematol. 2020;191:e38-e40.
    PubMed    


  80. PIKE A, Muus P, Munir T, Mitchell L, et al
    COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience.
    Br J Haematol. 2020;191:e1-e4.
    PubMed    


  81. ROIZENBLATT S, Cabanas-Pedro AC, Figueiredo MS
    Rheumatoid arthritis and sickle cell disease: A potential association.
    Br J Haematol. 2020;191:e25-e28.
    PubMed    


  82. BARGEHR C, Crazzolara R
    Cabot rings and other peripheral blood features of Imerslund-Grasbeck syndrome.
    Br J Haematol. 2020;191:11.
    PubMed    


  83. TEOFILI L, Papacci P, Orlando N, Bianchi M, et al
    Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study.
    Br J Haematol. 2020;191:263-268.
    PubMed     Abstract available


  84. RICCHI P, Meloni A, Pistoia L, Spasiano A, et al
    Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
    Br J Haematol. 2020;191:107-114.
    PubMed     Abstract available


    September 2020
  85. NESR G, Koshy R, Foldes D, Kagdi H, et al
    Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-naive chronic lymphocytic leukaemia: a case report.
    Br J Haematol. 2020;190:e326-e328.
    PubMed    


  86. OLATUNYA OS
    Poverty and severity of childhood sickle cell disease.
    Br J Haematol. 2020;190:819-821.
    PubMed    


  87. WOUTERS HJCM, Stam SP, van der Klauw MM, Bakker SJL, et al
    The association between haemoglobin concentrations and muscle mass determined from urinary creatinine excretion rate: a population-based cohort study.
    Br J Haematol. 2020;190:e349-e352.
    PubMed    


  88. GERARD D, Bourin S, Phulpin A, Picard V, et al
    Previously misdiagnosed red cell membrane disorder and familial consequences.
    Br J Haematol. 2020;190:810.
    PubMed    


  89. LIAPIS K, Vrachiolias G, Spanoudakis E, Kotsianidis I, et al
    Vacuolation of early erythroblasts with ring sideroblasts: a clue to the diagnosis of linezolid toxicity.
    Br J Haematol. 2020;190:809.
    PubMed    


  90. MCGINNIS E, Smith TW
    Clostridium perfringens sepsis with spherocytosis and green neutrophil inclusions.
    Br J Haematol. 2020;190:641.
    PubMed    


  91. DE SANTIS GC, Costa TCM, Santos FLS, da Silva-Pinto AC, et al
    Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation: a single-institution experience.
    Br J Haematol. 2020;190:e295-e297.
    PubMed    


  92. BELLO-MANGA H, Galadanci AA, Abdullahi S, Ali S, et al
    Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial.
    Br J Haematol. 2020;190:939-944.
    PubMed     Abstract available


    August 2020
  93. KULASEKARARAJ AG, Lazana I, Large J, Posadas K, et al
    Terminal complement inhibition dampens the inflammation during COVID-19.
    Br J Haematol. 2020;190:e141-e143.
    PubMed    


  94. KARIMI M, Haghpanah S, Azarkeivan A, Zahedi Z, et al
    Prevalence and mortality in beta-thalassaemias due to outbreak of novel coronavirus disease (COVID-19): the nationwide Iranian experience.
    Br J Haematol. 2020;190:e137-e140.
    PubMed    


  95. APPIAH-KUBI A, Acharya S, Fein Levy C, Vlachos A, et al
    Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases.
    Br J Haematol. 2020;190:e221-e224.
    PubMed    


  96. KULASEKARARAJ AG
    Regulatory cells in immune-mediated aplastic anaemia - not Tregs but Bregs.
    Br J Haematol. 2020;190:486-487.
    PubMed    


  97. GIBSON JS
    A novel mechanism for pathogenesis of sickle cell disease with therapeutic implications: Band 3 tyrosine phosphorylation.
    Br J Haematol. 2020;190:488-489.
    PubMed    


  98. COLOMBATTI R, Andemariam B
    Microvasculopathy and biomarkers in sickle cell disease: the promise of non-invasive real-time in vivo tools.
    Br J Haematol. 2020;190:309-310.
    PubMed    


  99. MALINOWSKI AK
    Thrombotic microangiopathy in pregnancy: when you hear hoofbeats, consider the zebras?
    Br J Haematol. 2020;190:306-308.
    PubMed    


  100. MOURA PL, Dobbe JGG, Streekstra GJ, Rab MAE, et al
    Rapid diagnosis of hereditary haemolytic anaemias using automated rheoscopy and supervised machine learning.
    Br J Haematol. 2020;190:e250-e255.
    PubMed    


  101. ANDREWS C, Maze D, Murphy T, Sibai H, et al
    Combination treatment with CPX-351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature.
    Br J Haematol. 2020;190:467-470.
    PubMed    


  102. FILIPPIDOU M, Avgerinou G, Tsipou H, Tourkantoni N, et al
    Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
    Br J Haematol. 2020;190:e157-e159.
    PubMed    


  103. FUNG EB, Ahmad T, Killilea DW, Hussain R, et al
    Zinc supplementation improves markers of glucose homeostasis in thalassaemia.
    Br J Haematol. 2020;190:e162-e166.
    PubMed    


  104. LUEWAN S, Charoenkwan P, Sirichotiyakul S, Tongsong T, et al
    Fetal haemoglobin H-Constant Spring disease: a role for intrauterine management.
    Br J Haematol. 2020;190:e233-e236.
    PubMed    


  105. NOOMUNA P, Risinger M, Zhou S, Seu K, et al
    Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.
    Br J Haematol. 2020;190:599-609.
    PubMed     Abstract available


  106. TIMMERMANS SAMEG, Werion A, Spaanderman MEA, Reutelingsperger CP, et al
    The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives.
    Br J Haematol. 2020;190:442-449.
    PubMed     Abstract available


  107. ZAIMOKU Y, Patel BA, Kajigaya S, Feng X, et al
    Deficit of circulating CD19(+) CD24(hi) CD38(hi) regulatory B cells in severe aplastic anaemia.
    Br J Haematol. 2020;190:610-617.
    PubMed     Abstract available


  108. SAMARRON SL, Miller JW, Cheung AT, Chen PC, et al
    Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients.
    Br J Haematol. 2020;190:450-457.
    PubMed     Abstract available


  109. WILSON S, Ellsworth P, Key NS
    Pregnancy in sickle cell trait: what we do and don't know.
    Br J Haematol. 2020;190:328-335.
    PubMed     Abstract available


    July 2020
  110. HEILBRONNER C, Berteloot L, Tremolieres P, Dupic L, et al
    Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit.
    Br J Haematol. 2020;190:e21-e24.
    PubMed    


  111. SAHU KK, Siddiqui AD, Cerny J
    Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience.
    Br J Haematol. 2020;190:e86-e89.
    PubMed    


  112. LI M, Nguyen CB, Yeung Z, Sanchez K, et al
    Evans syndrome in a patient with COVID-19.
    Br J Haematol. 2020;190:e59-e61.
    PubMed    


  113. MCCLOSKEY KA, Meenan J, Hall R, Tsitsikas DA, et al
    COVID-19 infection and sickle cell disease: a UK centre experience.
    Br J Haematol. 2020;190:e57-e58.
    PubMed    


  114. CHAKRAVORTY S, Rees D
    Commentary on sickle cell non-invasive prenatal testing article.
    Br J Haematol. 2020;190:20-21.
    PubMed    


  115. JEREBTSOVA M, Taye A, Smith N, Afangbedji N, et al
    Association between plasma and urinary orosomucoid and chronic kidney disease in adults with sickle cell disease.
    Br J Haematol. 2020;190:e45-e48.
    PubMed    


  116. PEDROSA AM, Lemes RPG
    Gene expression of HIF-1alpha and VEGF in response to hypoxia in sickle cell anaemia: Influence of hydroxycarbamide.
    Br J Haematol. 2020;190:e39-e42.
    PubMed     Abstract available


  117. NARDO-MARINO A, Brousse V, Rees D
    Emerging therapies in sickle cell disease.
    Br J Haematol. 2020;190:149-172.
    PubMed     Abstract available


  118. KATTAMIS A
    Diamond-Blackfan anaemia: understanding an old disease.
    Br J Haematol. 2020;190:14-15.
    PubMed    


  119. VAN CAMPEN J, Silcock L, Yau S, Daniel Y, et al
    A novel non-invasive prenatal sickle cell disease test for all at-risk pregnancies.
    Br J Haematol. 2020;190:119-124.
    PubMed     Abstract available


  120. QUARELLO P, Garelli E, Carando A, Cillario R, et al
    A 20-year long term experience of the Italian Diamond-Blackfan Anaemia Registry: RPS and RPL genes, different faces of the same disease?
    Br J Haematol. 2020;190:93-104.
    PubMed     Abstract available


    June 2020
  121. HUSSAIN FA, Njoku FU, Saraf SL, Molokie RE, et al
    COVID-19 infection in patients with sickle cell disease.
    Br J Haematol. 2020;189:851-852.
    PubMed    


  122. LUZZATTO L
    PNH phenotypes and their genesis.
    Br J Haematol. 2020;189:802-805.
    PubMed    


  123. HYACINTH HI, Idris IM
    Cognitive deficit in sickle cell disease: Is hydroxyurea part of the story?
    Br J Haematol. 2020;189:1014-1015.
    PubMed    


  124. GIRELLI D, Busti F
    ERFE regulation in sickle cell disease: complex but promising.
    Br J Haematol. 2020;189:1012-1013.
    PubMed    


  125. KHAMPHIKHAM P, Nualkaew T, Pongpaksupasin P, Kaewsakulthong W, et al
    High-level induction of fetal haemoglobin by pomalidomide in beta-thalassaemia/HbE erythroid progenitor cells.
    Br J Haematol. 2020;189:e240-e245.
    PubMed    


  126. BREWIN JN, Crowley MP, Kesse-Adu R, Stuart-Smith S, et al
    Catheter associated thromboses in patients with sickle cell anaemia and dual lumen Vortex apheresis ports are common and can be clinically asymptomatic.
    Br J Haematol. 2020;189:e198-e200.
    PubMed    


  127. PARTANEN M, Kang G, Wang WC, Krull K, et al
    Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease.
    Br J Haematol. 2020;189:1192-1203.
    PubMed     Abstract available


  128. RICHARDS SJ, Dickinson AJ, Cullen MJ, Griffin M, et al
    Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry.
    Br J Haematol. 2020;189:954-966.
    PubMed     Abstract available


  129. PRATS-MARTIN C, Mezquita L, Garcia-Canale S, Jimenez-Jambrina M, et al
    Numerous abnormal mitoses in parvovirus B19-infected proerythroblasts.
    Br J Haematol. 2020;189:800.
    PubMed    


  130. MANGAONKAR AA, Thawer F, Son J, Ajebo G, et al
    Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.
    Br J Haematol. 2020;189:1204-1209.
    PubMed     Abstract available


  131. AL-ALI HK, Griesshammer M, Foltz L, Palumbo GA, et al
    Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
    Br J Haematol. 2020;189:888-903.
    PubMed     Abstract available


  132. PATEL BJ, Barot SV, Kuzmanovic T, Kerr C, et al
    Distinctive and common features of moderate aplastic anaemia.
    Br J Haematol. 2020;189:967-975.
    PubMed     Abstract available


    May 2020
  133. ZAGORSKI E, Pawar T, Rahimian S, Forman D, et al
    Cold Agglutinin Autoimmune Hemolytic Anemia Associated with Novel Coronavirus (COVID-19).
    Br J Haematol. 2020 May 27. doi: 10.1111/bjh.16892.
    PubMed     Abstract available


  134. ANGILERI F, Legare S, Marino Gammazza A, Conway de Macario E, et al
    Is molecular mimicry the culprit in the autoimmune hemolytic anemia affecting COVID-19 patients?
    Br J Haematol. 2020 May 26. doi: 10.1111/bjh.16883.
    PubMed     Abstract available


  135. LAZARIAN G, Quinquenel A, Bellal M, Siavellis J, et al
    Autoimmune hemolytic anemia associated with Covid-19 infection.
    Br J Haematol. 2020 May 6. doi: 10.1111/bjh.16794.
    PubMed     Abstract available


  136. LOPEZ C, Kim J, Pandey A, Huang T, et al
    Simultaneous Onset of COVID-19 and Autoimmune Hemolytic Anemia.
    Br J Haematol. 2020 May 5. doi: 10.1111/bjh.16786.
    PubMed     Abstract available


  137. ROY NBA, Telfer P, Eleftheriou P, de la Fuente J, et al
    Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic.
    Br J Haematol. 2020;189:635-639.
    PubMed     Abstract available


  138. ANTELO G, Mangaonkar AA, Coltro G, Buradkar A, et al
    Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
    Br J Haematol. 2020;189:e104-e108.
    PubMed    


  139. SHAH BN, Hassan TO, Zhang X, McClain DA, et al
    Increased iron stores influence glucose metabolism in sickle cell anaemia.
    Br J Haematol. 2020;189:e184-e187.
    PubMed    


  140. SKINNER S, Ling Liu K, Lo M, Josset-Lamaugarny A, et al
    Alterations in vascular reactivity in a transgenic mouse model of sickle cell trait.
    Br J Haematol. 2020;189:e154-e157.
    PubMed    


  141. GOUVEIA C, Duarte M, Norte S, Alves P, et al
    Osteoarticular infections in paediatric sickle cell disease: in the era of multidrugresistant bacteria.
    Br J Haematol. 2020;189:e147-e150.
    PubMed    


  142. PHILIP KEJ, Sadaka AS, Polkey MI, Hopkinson NS, et al
    The prevalence and associated mortality of non-anaemic iron deficiency in older adults: a 14 years observational cohort study.
    Br J Haematol. 2020;189:566-572.
    PubMed     Abstract available


  143. LEONARD A, Tisdale J, Abraham A
    Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
    Br J Haematol. 2020;189:408-423.
    PubMed     Abstract available


  144. MCCORMICK M, Richardson T, Warady BA, Novelli EM, et al
    Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization.
    Br J Haematol. 2020;189:559-565.
    PubMed     Abstract available


    April 2020
  145. ALI JS, Andrasik F, Berlin KS, Porter J, et al
    Attention difficulties are associated with lower engagement in adult care amongst youth with sickle cell disease.
    Br J Haematol. 2020;189:e27-e30.
    PubMed    


  146. FAYAND A, Dzierzynski N, Georgin-Lavialle S, Bachmeyer C, et al
    The association of psychiatric comorbidities with emergency visits and hospitalisations in adult sickle-cell patients: a cohort study.
    Br J Haematol. 2020;189:e21-e23.
    PubMed    


  147. ROPER D, Layton M, Rees D, Lambert C, et al
    Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline.
    Br J Haematol. 2020;189:24-38.
    PubMed    


  148. THIENGTAVOR C, Siriworadetkun S, Paiboonsukwong K, Fucharoen S, et al
    Increased ferritin levels in non-transfusion-dependent beta degrees -thalassaemia/HbE are associated with reduced CXCR2 expression and neutrophil migration.
    Br J Haematol. 2020;189:187-198.
    PubMed     Abstract available


  149. FUJISAWA M, Yasumoto A, Kato H, Sugawara Y, et al
    The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function.
    Br J Haematol. 2020;189:182-186.
    PubMed     Abstract available


  150. NICKEL RS, Horan JT, Abraham A, Qayed M, et al
    Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.
    Br J Haematol. 2020;189:162-170.
    PubMed     Abstract available


  151. QUARTA A, Sgherza N, Pasanisi A, Solfrizzi MP, et al
    Switching from dispersible to film coated tablet formulation of deferasirox improves hemoglobin levels and transfusional interval in patients with transfusion-dependent-thalassemia.
    Br J Haematol. 2020;189:e60-e63.
    PubMed    


    March 2020
  152. AUERBACH M, Georgieff MK
    Guidelines for iron deficiency in pregnancy: hope abounds: Commentary to accompany: UK guidelines on the management of iron deficiency in pregnancy.
    Br J Haematol. 2020;188:814-816.
    PubMed    


  153. AGGARWAL A, Jamwal M, Sharma P, Sachdeva MUS, et al
    Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study.
    Br J Haematol. 2020;188:784-795.
    PubMed     Abstract available


  154. HANSEN S, Wood DK, Higgins JM
    5-(Hydroxymethyl)furfural restores low-oxygen rheology of sickle trait blood in vitro.
    Br J Haematol. 2020;188:985-993.
    PubMed     Abstract available


  155. CORNELISSE AC, Bergkamp FJM, Griffioen-Keijzer A
    Haemolytic anaemia: an unrecognised side effect of hydroxyurea?
    Br J Haematol. 2020;188:e80-e81.
    PubMed    


  156. STALLINGS AM, Majhail NS, Nowacki AS, Onimoe GI, et al
    Paediatric haematologists' attitudes regarding haematopoietic cell transplantation as treatment for sickle cell disease.
    Br J Haematol. 2020;188:976-984.
    PubMed     Abstract available


  157. PAVORD S, Daru J, Prasannan N, Robinson S, et al
    UK guidelines on the management of iron deficiency in pregnancy.
    Br J Haematol. 2020;188:819-830.
    PubMed    


    February 2020
  158. NZE C, Fortin B, Freedman R, Mandell E, et al
    Sudden death in sickle cell disease: current experience.
    Br J Haematol. 2020;188:e43-e45.
    PubMed    


  159. SANCHEZ-PETITTO G, Drachenberg CB, Mannuel HD, Law JY, et al
    An unusual presentation of paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 2020;188:347.
    PubMed    


  160. SHAH S, Sheth R, Shah K, Patel K, et al
    Safety and effectiveness of thalidomide and hydroxyurea combination in beta-thalassaemia intermedia and major: a retrospective pilot study.
    Br J Haematol. 2020;188:e18-e21.
    PubMed    


  161. PEREIRA-MARTINS DA, Coelho-Silva JL, Domingos IF, Weinhauser I, et al
    Association between ANXA2*5681 polymorphism (rs7170178) and osteonecrosis in haemoglobin SS-genotyped patients.
    Br J Haematol. 2020;188:e8-e11.
    PubMed    


  162. DUTTA D, Aujla A, Knoll BM, Lim SH, et al
    Intestinal pathophysiological and microbial changes in sickle cell disease: Potential targets for therapeutic intervention.
    Br J Haematol. 2020;188:488-493.
    PubMed     Abstract available


  163. SAITO-BENZ M, Flanagan P, Berry MJ
    Management of anaemia in pre-term infants.
    Br J Haematol. 2020;188:354-366.
    PubMed     Abstract available


    January 2020
  164. SCHOLS S, Nunn MA, Mackie I, Weston-Davies W, et al
    Successful treatment of a PNH patient non-responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan).
    Br J Haematol. 2020;188:334-337.
    PubMed    


  165. WANG Y, McReynolds LJ, Dagnall C, Katki HA, et al
    Pre-transplant short telomeres are associated with high mortality risk after unrelated donor haematopoietic cell transplant for severe aplastic anaemia.
    Br J Haematol. 2020;188:309-316.
    PubMed     Abstract available


    April 2019
  166. RUND D
    Bittersweet news for the adult sickle cell patient.
    Br J Haematol. 2019;185:9-10.
    PubMed    


  167. ZHOU J, Han J, Nutescu EA, Galanter WL, et al
    Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis.
    Br J Haematol. 2019;185:116-127.
    PubMed     Abstract available


  168. NASHASHIBI J, Avraham GR, Schwartz N, Awni Y, et al
    Intravenous iron treatment reduces coagulability in patients with iron deficiency anaemia: a longitudinal study.
    Br J Haematol. 2019;185:93-101.
    PubMed     Abstract available


  169. BELISARIO AR, Vieira ELM, de Almeida JA, Mendes FG, et al
    Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia.
    Br J Haematol. 2019;185:190-193.
    PubMed    


  170. MORISSENS M, Castro Rodriguez J, Azerad MA, Besse-Hammer T, et al
    Added value of speckle tracking in the evaluation of cardiac function in patients with sickle cell disease.
    Br J Haematol. 2019;185:151-153.
    PubMed    


  171. BRUNSON A, Keegan THM, Mahajan A, Paulukonis S, et al
    Cancer specific survival in patients with sickle cell disease.
    Br J Haematol. 2019;185:128-132.
    PubMed     Abstract available


  172. DAY ME, Rodeghier M, Driggers J, Bean CJ, et al
    A significant proportion of children of African descent with HbSbeta(0) thalassaemia are inaccurately diagnosed based on phenotypic analyses alone.
    Br J Haematol. 2019;185:153-156.
    PubMed    


    March 2019
  173. GRACE RF, Mark Layton D, Barcellini W
    How we manage patients with pyruvate kinase deficiency.
    Br J Haematol. 2019;184:721-734.
    PubMed     Abstract available


  174. WHITE J, Lindgren M, Liu K, Gao X, et al
    Sevuparin blocks sickle blood cell adhesion and sickle-leucocyte rolling on immobilized L-selectin in a dose dependent manner.
    Br J Haematol. 2019;184:873-876.
    PubMed    


  175. PELLEGRIN S, Haydn-Smith KL, Hampton-O'Neil LA, Hawley BR, et al
    Transduction with BBF2H7/CREB3L2 upregulates SEC23A protein in erythroblasts and partially corrects the hypo-glycosylation phenotype associated with CDAII.
    Br J Haematol. 2019;184:876-881.
    PubMed    


  176. ALTER BP, Giri N
    Serum alpha fetoprotein levels in Fanconi anaemia.
    Br J Haematol. 2019;184:1074-1076.
    PubMed    


  177. BERGER G, van den Berg E, Smetsers S, Leegte BK, et al
    Fanconi anaemia presenting as acute myeloid leukaemia and myelodysplastic syndrome in adulthood: a family report on co-occurring FANCC and CHEK2 mutations.
    Br J Haematol. 2019;184:1071-1073.
    PubMed    


  178. JIANG H, Zhang H, Wang Y, Qi W, et al
    Sirolimus for the treatment of multi-resistant pure red cell aplasia.
    Br J Haematol. 2019;184:1055-1058.
    PubMed    


  179. SALEM B, Mitchell R, DeFor TE, Tryon R, et al
    Elevations in serum alpha fetoprotein levels in patients with Fanconi anaemia.
    Br J Haematol. 2019;184:1032-1035.
    PubMed    


  180. KANTER J, Heath LE, Knorr J, Agbenyega ET, et al
    Novel findings from the multinational DOVE study on geographic and age-related differences in pain perception and analgesic usage in children with sickle cell anaemia.
    Br J Haematol. 2019;184:1058-1061.
    PubMed    


    February 2019
  181. MCGOWAN KE, Malinowski AK, Schuh AC, Whittle W, et al
    Aplastic anaemia in pregnancy - a single centre, North American series.
    Br J Haematol. 2019;184:436-439.
    PubMed     Abstract available


  182. LUZZATTO L, Notaro R
    The "escape" model: a versatile mechanism for clonal expansion.
    Br J Haematol. 2019;184:465-466.
    PubMed    


  183. RAVERA S, Degan P, Sabatini F, Columbaro M, et al
    Altered lipid metabolism could drive the bone marrow failure in fanconi anaemia.
    Br J Haematol. 2019;184:693-696.
    PubMed    


  184. DARBARI DS, Liljencrantz J, Ikechi A, Martin S, et al
    Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant.
    Br J Haematol. 2019;184:690-693.
    PubMed    


  185. MARKUS C, Saxon B, Metz M
    Ferritin as a functional biomarker of iron status in children and young adults.
    Br J Haematol. 2019;184:640-642.
    PubMed    


  186. MALINOWSKI AK, Cheung P, Yang J, D'Souza R, et al
    Cord gas parameters in infants born to women with sickle cell disease: a retrospective matched cohort study.
    Br J Haematol. 2019;184:653-657.
    PubMed    


  187. MAJUMDAR S, Tirona R, Mashegu H, Desai J, et al
    A phase 1 dose-finding study of intravenous L-citrulline in sickle cell disease: a potential novel therapy for sickle cell pain crisis.
    Br J Haematol. 2019;184:634-636.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: